ACCOUNTS - Final Accounts


Caseware UK (AP4) 2021.0.152 2021.0.152 2021-06-302021-06-302020-07-01falseConsultancy and software23falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 06820444 2020-07-01 2021-06-30 06820444 2019-07-01 2020-06-30 06820444 2021-06-30 06820444 2020-06-30 06820444 c:CompanySecretary1 2020-07-01 2021-06-30 06820444 c:Director2 2020-07-01 2021-06-30 06820444 c:Director3 2020-07-01 2021-06-30 06820444 c:RegisteredOffice 2020-07-01 2021-06-30 06820444 d:CurrentFinancialInstruments 2021-06-30 06820444 d:CurrentFinancialInstruments 2020-06-30 06820444 d:Non-currentFinancialInstruments 2021-06-30 06820444 d:Non-currentFinancialInstruments 2020-06-30 06820444 d:CurrentFinancialInstruments d:WithinOneYear 2021-06-30 06820444 d:CurrentFinancialInstruments d:WithinOneYear 2020-06-30 06820444 d:Non-currentFinancialInstruments d:AfterOneYear 2021-06-30 06820444 d:Non-currentFinancialInstruments d:AfterOneYear 2020-06-30 06820444 d:ShareCapital 2021-06-30 06820444 d:ShareCapital 2020-06-30 06820444 d:RetainedEarningsAccumulatedLosses 2021-06-30 06820444 d:RetainedEarningsAccumulatedLosses 2020-06-30 06820444 c:OrdinaryShareClass1 2020-07-01 2021-06-30 06820444 c:OrdinaryShareClass1 2021-06-30 06820444 c:OrdinaryShareClass1 2020-06-30 06820444 c:FRS102 2020-07-01 2021-06-30 06820444 c:Audited 2020-07-01 2021-06-30 06820444 c:FullAccounts 2020-07-01 2021-06-30 06820444 c:PrivateLimitedCompanyLtd 2020-07-01 2021-06-30 06820444 c:SmallCompaniesRegimeForAccounts 2020-07-01 2021-06-30 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 06820444








PATIENTRACK (UK) LIMITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 30 JUNE 2021

 
PATIENTRACK (UK) LIMITED
 

COMPANY INFORMATION


Directors
K. E. Doyle 
M. J. Gepp 




Company secretary
M. J. Leydin



Registered number
06820444



Registered office
1st Floor Sackville House
143-149 Fenchurch Street

London

EC3M 6BN




Independent auditors
DSG

43 Castle Street

Liverpool

L2 9TL





 
PATIENTRACK (UK) LIMITED
 

CONTENTS



Page
Balance Sheet
 
1
Notes to the Financial Statements
 
2 - 6


 
PATIENTRACK (UK) LIMITED
REGISTERED NUMBER: 06820444

BALANCE SHEET
AS AT 30 JUNE 2021

2021
2020
Note
£
£

  

Current assets
  

Debtors
 4 
494,718
592,364

Creditors: amounts falling due within one year
 5 
(155,048)
(530,068)

Net current assets
  
 
 
339,670
 
 
62,296

Creditors: amounts falling due after more than one year
 6 
(94,763)
-

Net assets
  
244,907
62,296


Capital and reserves
  

Called up share capital 
 7 
1
1

Profit and loss account
  
244,906
62,295

  
244,907
62,296


The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements..
The Company's financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The Company has opted not to file the Directors' Report and the Statement of Income and Retained Earnings in accordance with provisions applicable to companies subject to the small companies regime, under section 444 of the Companies Act 2006.


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 
27 June 2022.




M. J. Gepp
Director

The notes on pages 2 to 6 form part of these financial statements.

Page 1

 
PATIENTRACK (UK) LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2021

1.


GENERAL INFORMATION

Patientrack (UK) Limited (company number 06820444) having its registered office at 1st Floor Sackville House, 143-149 Fenchurch Street, London, EC3M 6BN, is a limited company incorporated in England and Wales. Its trading address is Suite 3, 185 Fleet Road, Fleet, Hampshire, GU51 3BL.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

  
2.2

STATEMENT OF CASH FLOWS

The Company has taken advantage of the exemption in Financial Reporting Standard 102, Section 1A.7 from the requirement to produce a Statement of Cash Flows on the grounds that it is a small company.

 
2.3

GOING CONCERN

The directors have considered whether the Company has been affected by the economic impact and restrictions that have ensued following the emergence of the coronavirus pandemic. Having considered pre and post year end trading as well as the financial results, support from group companies, and after making enquiries, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least 12 months from the date these financial statements were approved. Accordingly they continue to adopt the going concern basis in preparing the financial statements.

 
2.4

FOREIGN CURRENCY TRANSLATION

Functional and presentation currency

The Company's functional and presentational currency is British Pound Sterling GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of Income and Retained Earnings.

Page 2

 
PATIENTRACK (UK) LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2021

2.ACCOUNTING POLICIES (CONTINUED)

 
2.5

TURNOVER

Turnover is derived from the provision of goods and services through the main income streams: Licence, Support and Maintenance, and Product implementation.
Licence turnover arising from the provision of medical software is recognised proportionately at initial installation of the product and when ready for 'go live' use by the customer at completion of the implementation phase.
Turnover arising from the support and maintenance services provided to the customer is recognised across the period specified in the contract. Often the period specified spans the financial year end date and the deferred income element of the invoice is included within accruals and deferred income.
Turnover arising from the implementation of the products sold is recognised across the period specified in the contract.
All turnover is recognised exclusive of VAT.

 
2.6

OPERATING LEASES: THE COMPANY AS LESSEE

Rentals paid under operating leases are charged to the Statement of Income and Retained Earnings on a straight line basis over the lease term.

 
2.7

PENSIONS

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Statement of Income and Retained Earnings when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 
PATIENTRACK (UK) LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2021

2.ACCOUNTING POLICIES (CONTINUED)

 
2.8

TAXATION

Tax is recognised in the Statement of Income and Retained Earnings except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.

 
2.9

DEBTORS

Short-term debtors are measured at transaction price, less any impairment.

 
2.10

CREDITORS

Short-term creditors are measured at the transaction price. 

 
2.11

FINANCIAL INSTRUMENTS

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the Balance Sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 2 (2020 - 7).

Page 4

 
PATIENTRACK (UK) LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2021

4.


DEBTORS

2021
2020
£
£

Amounts falling due within one year

Amounts owed by group undertakings
494,465
592,364

Prepayments and accrued income
253
-

494,718
592,364



5.


CREDITORS: Amounts falling due within one year

2021
2020
£
£

Amounts owed to group undertakings
8,122
8,376

Corporation tax
20,737
-

Other creditors
1,659
1,659

Accruals and deferred income
124,530
520,033

155,048
530,068



6.


CREDITORS: Amounts falling due after more than one year

2021
2020
£
£

Accruals and deferred income
94,763
-

94,763
-



7.


SHARE CAPITAL

2021
2020
£
£
Allotted, called up and fully paid



1 (2020 - 1) Ordinary share of £1.00
1
1



8.


PENSION COMMITMENTS

The company operates a defined contribution pension plan. The assets of the plan are held separately from those of the company in independently-administered funds. The pension costs represent contributions payable by the company to the fund and amount to £Nil (2020: £3,180). At the year-end there were contributions outstanding of £1,659 (2020: £1,659).

Page 5

 
PATIENTRACK (UK) LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2021

9.


RELATED PARTY TRANSACTIONS

The Company has taken advantage of the exemption in FRS 102 Section 33.1A not to disclose transactions with group entities on the grounds that it is a wholly-owned subsidiary undertaking.


10.


IMMEDIATE AND ULTIMATE PARENT UNDERTAKING

The immediate parent undertaking is Alcidion UK Limited, a company incorporated in England and Wales.
The ultimate parent entity is Alcidion Group Limited, a company incorporated in Australia and which prepares group financial statements. 
The registered office of Alcidion Group Limited is Level 4, 100 Albert Road, South Melbourne, VIC 3205.


11.


AUDITORS' INFORMATION

The Company was subject to an audit for the year ended 30 June 2021. The audit report was issued by Iain White BSc FCA as Senior Statutory Auditor of DSG with an unqualified opinion.28/06/2022


Page 6